Adaptive Biotechnologies Corporation (ADPT)
NASDAQ·Healthcare·Biotechnology
$28.71
+2.84%
Mkt Cap $4.47B
Analyst Ratings
Buy
9
Hold
3
Sell
0
Price Target (20 analysts)
$30.42
Range $20.00 – $35.00
Implied Upside
+6.0%
Consensus $30.42 vs current $28.71